Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris

NCT03806790 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT03806790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03806790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris
Lead sponsor
LEO Pharma
Phase
Phase 3
Overall status
Completed
Start date
January 24, 2019
Completion date
June 10, 2019
Enrollment
182 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris